Table 1 Clinical characteristics of patients

Patients

29

Age, median (range)

76 (56–89)

<75

≥75

Gender

male

20

female

9

PS

0

2

1

22

2

5

T-stage

T2a

18

T2b

2

T3

9

Location of the tumor 1

lower lobe

11

middle, upper lobe

18

Location of the tumor 2

near the pulmonary hilum

8

Peripheral

21

Pathology

squamous carcinoma

17

adenocarcinoma

12

Dose (Gy), median (range)

60 (48–60)

48Gy, 3Gy/f

1

50Gy, 5Gy/f

3

54Gy, 6Gy/f or 3Gy

2

60Gy, 3Gy/f

2

60Gy, 4Gy/f

8

60Gy, 5Gy/f

10

60Gy, 6Gy/f

3

BED (Gy), median (range)

84 (67.2-90)

<80 Gy

14

≥80 Gy

15

Fraction size (Gy)

3

7

4

5

5

15

6

2

Chemotherapy

TS-1

neoadjuvant

1

concurrent

1

adjuvant

1

UFT

concurrent

1